Phase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancer
Guardado en:
Autores principales: | Ravi A Madan, Christopher Heery, Claudia Palena, Caroline Jochems, Julius Strauss, Marijo Bilusic, Fatima Karzai, Jennifer L Marté, Charalampos Floudas, Peter J DeMaria, Katherine Lee-Wisdom, Angie Schwab, Jason Mark Redman, Eva Dombi, Brigitte Widemann, Borys Korchin, Tatiana Adams, Cesar Pico-Navarro |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/37a0f2d29a6c47d6940c4dc1bf5400ca |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Genomic targets of Brachyury (T) in differentiating mouse embryonic stem cells.
por: Amanda L Evans, et al.
Publicado: (2012) -
Mechanism of pyocyanin abolishment caused by mvaT mvaU double knockout in Pseudomonas aeruginosa PAO1
por: Limin Dong, et al.
Publicado: (2020) -
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa.
por: Houreratou Barry, et al.
Publicado: (2021) -
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa
por: Houreratou Barry, et al.
Publicado: (2021) -
Localization to delocalization probed by magnetotransport of hBN/graphene/hBN stacks in the ultra-clean regime
por: Takuya Iwasaki, et al.
Publicado: (2021)